Long intergenic non-protein coding RNA 1326 (LINC01326)

LINC01326 (Long intergenic non-protein coding RNA 1326) is a human long intergenic non-coding RNA, defined by being longer than 200 nucleotides and autonomously transcribed from intergenic regions, without overlapping protein-coding genes[1][5]. LincRNAs, including LINC01326, are a subclass of long non-coding RNAs noted for their tissue specificity and diverse regulatory roles in gene expression, chromatin architecture, and potentially enhancer function within the genome[1]. While a small fraction of lincRNAs have experimentally validated gene-regulatory roles, most—including LINC01326—lack detailed functional characterization. There are no established disease associations, therapeutic interactions, or applications for LINC01326, nor is it classified as an enzyme, transporter, receptor, or other canonical drug target class. The gene is correctly named and annotated, per GWAS and current transcriptomic databases[5].\n\nKey points:\n- LINC01326 is a lincRNA, not a protein-coding receptor or therapeutic drug target.\n- No clinically relevant drugs, mechanisms, or biomarker roles are reported for this gene.\n- Correctly named and not misspelled; primary aliases are standardized per current gene and transcript databases.\n- General biological functions reflect the broader role of lincRNAs, not specific evidence for LINC01326.\n\nIf future research reveals novel associations with disease or therapeutic relevance for LINC01326, its role and classification may be updated accordingly.

Other names

LINC01326TCONS_00005878